Kidney Transplantation Clinical Trials

A listing of Kidney Transplantation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
A Study to Evaluate Safety Tolerability Pharmacokinetics and Efficacy of UCB7858 in Adult Kidney Transplant Recipients With Chronic Allograft Injury

The main purpose of Stage 1 in this study is to investigate the safety and tolerability of UCB7858 in kidney transplant recipients with deteriorating kidney function associated with chronic

  • 45 views
  • 01 Aug, 2021
  • 7 locations
Envarsus XR Compared to Immediate Release Tacrolimus

The purpose of this study is to compare once-daily tacrolimus extended-release (Envarsus XR) to twice-daily immediate release tacrolimus to find out if people taking tacrolimus extended release (Envarsus XR) report fewer side effects, increased medication compliance and higher scores on quality of life assessments compared to people taking twice daily …

  • 0 views
  • 31 Jul, 2021
  • 3 locations
A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

A randomized controlled study to assess the safety and efficacy and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.

  • 23 views
  • 22 Jul, 2021
  • 15 locations
Motivational Interviewing for Adult Kidney Transplant Recipients

Purpose: This study aimed to determine the effect of motivational interviewing on self-management of treatment regimen, medication adherence, and patient outcomes in adult kidney transplant

kidney transplant
  • 0 views
  • 19 Jul, 2021
  • 1 location
Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients

immunosuppressive (IS) treatment groups: delayed or standard Prograf together with induction therapy, and then convert to Advagraf usage in donation after cardiac (or circulatory) death (DCD) kidney transplant

advagraf
prograf
mycophenolic acid
immunosuppressive agents
tacrolimus
  • 5 views
  • 01 Aug, 2021
  • 15 locations
Enhancing Renal Graft Function During Donor Anesthesia

Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the

kidney transplant
nephropathy
induction of anesthesia
  • 2 views
  • 01 Aug, 2021
  • 1 location
Use of CGM in Kidney Transplant Recipients

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney

  • 0 views
  • 27 Jul, 2021
  • 1 location
Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?

This study is a randomised, controlled, phase II trial to assess the efficacy of 2 hours normothermic machine perfusion (NMP) of extended criteria(EC)-DBD (donation after brain death) and DCD (donation after circulatory death) donor kidneys compared to standard care, which is hypothermic machine perfusion (HMP) only in the Netherlands.

  • 0 views
  • 31 Jul, 2021
  • 1 location
A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

The purpose of this study is to evaluate the efficacy, safety and tolerability of dual costimulation blockade with VIB4920 in combination of belatacept in adult male or female recipients of a renal allograft from a deceased, living unrelated or human leukocyte antigen (HLA) non-identical living related donor.

kidney transplant
immunization schedules
belatacept
cross-match
vaccination
  • 24 views
  • 29 Jul, 2021
  • 2 locations
The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients

This is a Phase 2 Multi-Center Clinical Trial (safety and effectiveness trial) in 60 patients (40 denosumab; 20 placebo) who have had a kidney transplant for 12-months or longer with more than

bone mineral density
metabolic bone disease
dental procedure
dual-energy x-ray absorptiometry
calcium
  • 3 views
  • 22 Jul, 2021
  • 2 locations